ROMEG Therapeutics
Manufacturing · Massachusetts, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
400 Tradecenter Ste 5900, Woburn, Massac...Phone Number
(781) 569-5866Website
www.romegrx.comRevenue
$20.2 MillionIndustry
About ROMEG Therapeutics
ROMEG Therapeutics Org Chart
Is ROMEG Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
ROMEG Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once ROMEG Therapeutics has new funding data
Product Launch: Get notified when ROMEG Therapeutics launches new products
Check out if ROMEG Therapeutics is spiking on competitors!
Earning: See what the market has to say on ROMEG Therapeutics recently announced quarterly report
Click to see if ROMEG Therapeutics had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at ROMEG Therapeutics
Check if ROMEG Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Recommended Actions
Reach out to Masked Content who joined ROMEG Therapeutics as Masked Content
Find 2 more new buyers
Compare Similar Companies to ROMEG Therapeutics
Compare insights from companies similar to ROMEG Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
ROMEG Therapeutics is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
ROMEG Therapeutics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about ROMEG Therapeutics.
ROMEG Therapeutics Tech Stack
A closer look at the technologies used by ROMEG Therapeutics
ROMEG Therapeutics News & Media
Romeg Therapeutics Announces Publication of RMG-03 Phase 2 Study Results in COVID-19
WOBURN, Mass., April 4, 2023 /PRNewswire/ -- ROMEG Therapeutics, LLC ("Romeg"), an innovative drug development company focused on alternative formulations to better meet clinical and patient needs, today announced the publication of results from its recently completed Phase 2 proof of...Romeg Therapeutics Announces Issuance of U.S. Patent for Pilocarpine Oral Solution
WOBURN, Mass., Feb. 1, 2023 /PRNewswire/ -- ROMEG Therapeutics, LLC ("Romeg"), an innovative drug development company focused on alternative formulations to better meet clinical and patient needs, today announced that the United States Patent and Trademark Office has issued U.S. Patent No....ROMEG Therapeutics Receives FDA Approval of GLOPERBA® (colchicine) for Prophylaxis of Adult Gout Flares
WOBURN, Mass.--(BUSINESS WIRE)--#arthritis--Romeg Therapeutics' GLOPERBA® is the first liquid formulation of colchicine approved by the FDA for the prophylaxis of gout flares in adults.
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding ROMEG Therapeutics
ROMEGA specializes in developing plant-based medicines aimed at treating a wide range of illnesses. The company focuses on addressing high unmet medical needs with innovative therapies, particularly in the area of gout treatment. Their flagship product, Gloperba, is the only FDA-approved oral solution for the prophylactic treatment of gout flares i... Read More